Growth & profitability
- Revenue has grown 120.2% per year over the past 3 years.
- Operating margin has expanded, at 20.3% in the latest year.
4 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $853M | $219M | 75.7% | 20.3% | $282M | — | $168M |
| 2024 | $396M | -$83M | 76.4% | -29.3% | $102M | — | $80M |
| 2023 | $116M | -$26M | 68.9% | -25.5% | -$15M | — | $45M |
| 2022 | $80M | -$58M | 73.5% | -75.4% | -$40M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $308M | $80M | 76.3% | 20.1% | $67M | — | $148M |
| Dec '25 | $271M | $45M | 75.6% | 24.7% | $77M | — | $168M |
| Sep '25 | $231M | $91M | 76.2% | 24.0% | $66M | — | $140M |
| Jun '25 | $192M | $51M | 75.8% | 20.7% | $133M | — | $162M |
| Mar '25 | $159M | $32M | 74.9% | 7.1% | $6M | — | $86M |
| Dec '24 | $141M | $25M | 74.0% | 0.1% | $24M | — | $80M |
| Sep '24 | $113M | -$8M | 77.7% | -7.9% | $47M | — | $126M |
| Jun '24 | $77M | -$8M | 77.9% | -31.7% | $31M | — | $421M |
| Mar '24 | $65M | -$93M | 77.4% | -127.1% | $228000 | — | $696M |
| Dec '23 | $51M | $14M | 77.3% | 17.9% | $13M | — | $45M |
| Sep '23 | $37M | -$3M | 76.1% | -5.4% | -$1M | — | — |
| Jun '23 | $11M | -$20M | 79.0% | -164.8% | -$24M | — | — |
| Mar '23 | $18M | -$17M | 24.1% | -107.2% | -$4M | — | — |
How the market has priced ALAB against its own fundamentals since 2024-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 3 years, Astera Labs, Inc.'s revenue has grown 120.2% per year. These are computed facts, not advice.
As of FY2025, Astera Labs, Inc. reported — of total debt against $168M of cash.
In FY2025, gross margin was 75.7%, operating margin 20.3%, and net margin 25.7%.
As of Jun '26, Astera Labs, Inc. traded at a price-to-earnings ratio of about 307.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.